NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel

Abstract Background The major dose-limiting toxicity of paclitaxel, one of the most commonly used drugs to treat solid tumor, is painful neuropathy. However, the molecular mechanisms underlying paclitaxel-induced painful neuropathy are largely unclarified. Methods Paw withdrawal threshold was measur...

Full description

Bibliographic Details
Main Authors: Meng Liu, Su-Bo Zhang, Yu-Xuan Luo, Yan-Ling Yang, Xiang-Zhong Zhang, Bo Li, Yan Meng, Yuan-Jie Chen, Rui-Xian Guo, Yuan-Chang Xiong, Wen-Jun Xin, Dai Li
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-020-01992-1
_version_ 1818229293139886080
author Meng Liu
Su-Bo Zhang
Yu-Xuan Luo
Yan-Ling Yang
Xiang-Zhong Zhang
Bo Li
Yan Meng
Yuan-Jie Chen
Rui-Xian Guo
Yuan-Chang Xiong
Wen-Jun Xin
Dai Li
author_facet Meng Liu
Su-Bo Zhang
Yu-Xuan Luo
Yan-Ling Yang
Xiang-Zhong Zhang
Bo Li
Yan Meng
Yuan-Jie Chen
Rui-Xian Guo
Yuan-Chang Xiong
Wen-Jun Xin
Dai Li
author_sort Meng Liu
collection DOAJ
description Abstract Background The major dose-limiting toxicity of paclitaxel, one of the most commonly used drugs to treat solid tumor, is painful neuropathy. However, the molecular mechanisms underlying paclitaxel-induced painful neuropathy are largely unclarified. Methods Paw withdrawal threshold was measured in the rats following intraperitoneal injection of paclitaxel. The qPCR, western blotting, protein or chromatin immunoprecipitation, ChIP-seq identification of NFATc2 binding sites, and microarray analysis were performed to explore the molecular mechanism. Results We found that paclitaxel treatment increased the nuclear expression of NFATc2 in the spinal dorsal horn, and knockdown of NFATc2 with NFATc2 siRNA significantly attenuated the mechanical allodynia induced by paclitaxel. Further binding site analysis utilizing ChIP-seq assay combining with gene expression profile revealed a shift of NFATc2 binding site closer to TTS of target genes in dorsal horn after paclitaxel treatment. We further found that NFATc2 occupancy may directly upregulate the chemokine CXCL14 expression in dorsal horn, which was mediated by enhanced interaction between NFATc2 and p300 and consequently increased acetylation of histone H4 in CXCL14 promoter region. Also, knockdown of CXCL14 in dorsal horn significantly attenuated mechanical allodynia induced by paclitaxel. Conclusion These results suggested that enhanced interaction between p300 and NFATc2 mediated the epigenetic upregulation of CXCL14 in the spinal dorsal horn, which contributed to the chemotherapeutic paclitaxel-induced chronic pain.
first_indexed 2024-12-12T10:16:18Z
format Article
id doaj.art-f2b86f125c4347bb9a3587344951ac27
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-12T10:16:18Z
publishDate 2020-10-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-f2b86f125c4347bb9a3587344951ac272022-12-22T00:27:39ZengBMCJournal of Neuroinflammation1742-20942020-10-0117111210.1186/s12974-020-01992-1NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxelMeng Liu0Su-Bo Zhang1Yu-Xuan Luo2Yan-Ling Yang3Xiang-Zhong Zhang4Bo Li5Yan Meng6Yuan-Jie Chen7Rui-Xian Guo8Yuan-Chang Xiong9Wen-Jun Xin10Dai Li11Neuroscience Program, The Fifth Affiliated Hospital of Sun Yat-Sen University, Guangdong Province Key Laboratory of Brain Function and Disease, Sun Yat-Sen UniversityNeuroscience Program, The Fifth Affiliated Hospital of Sun Yat-Sen University, Guangdong Province Key Laboratory of Brain Function and Disease, Sun Yat-Sen UniversityDepartment of Hematology, The Third Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Hematology, The Third Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Hematology, The Third Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Anesthesiology, Changhai Hospital, Naval Medical UniversityDepartment of Anesthesiology, Changhai Hospital, Naval Medical UniversityDepartment of Anesthesiology, Changhai Hospital, Naval Medical UniversityNeuroscience Program, The Fifth Affiliated Hospital of Sun Yat-Sen University, Guangdong Province Key Laboratory of Brain Function and Disease, Sun Yat-Sen UniversityDepartment of Anesthesiology, Changhai Hospital, Naval Medical UniversityNeuroscience Program, The Fifth Affiliated Hospital of Sun Yat-Sen University, Guangdong Province Key Laboratory of Brain Function and Disease, Sun Yat-Sen UniversityDepartment of Anesthesiology, Changhai Hospital, Naval Medical UniversityAbstract Background The major dose-limiting toxicity of paclitaxel, one of the most commonly used drugs to treat solid tumor, is painful neuropathy. However, the molecular mechanisms underlying paclitaxel-induced painful neuropathy are largely unclarified. Methods Paw withdrawal threshold was measured in the rats following intraperitoneal injection of paclitaxel. The qPCR, western blotting, protein or chromatin immunoprecipitation, ChIP-seq identification of NFATc2 binding sites, and microarray analysis were performed to explore the molecular mechanism. Results We found that paclitaxel treatment increased the nuclear expression of NFATc2 in the spinal dorsal horn, and knockdown of NFATc2 with NFATc2 siRNA significantly attenuated the mechanical allodynia induced by paclitaxel. Further binding site analysis utilizing ChIP-seq assay combining with gene expression profile revealed a shift of NFATc2 binding site closer to TTS of target genes in dorsal horn after paclitaxel treatment. We further found that NFATc2 occupancy may directly upregulate the chemokine CXCL14 expression in dorsal horn, which was mediated by enhanced interaction between NFATc2 and p300 and consequently increased acetylation of histone H4 in CXCL14 promoter region. Also, knockdown of CXCL14 in dorsal horn significantly attenuated mechanical allodynia induced by paclitaxel. Conclusion These results suggested that enhanced interaction between p300 and NFATc2 mediated the epigenetic upregulation of CXCL14 in the spinal dorsal horn, which contributed to the chemotherapeutic paclitaxel-induced chronic pain.http://link.springer.com/article/10.1186/s12974-020-01992-1PaclitaxelNFATc2CXCL14Histone acetylationNeuropathic pain
spellingShingle Meng Liu
Su-Bo Zhang
Yu-Xuan Luo
Yan-Ling Yang
Xiang-Zhong Zhang
Bo Li
Yan Meng
Yuan-Jie Chen
Rui-Xian Guo
Yuan-Chang Xiong
Wen-Jun Xin
Dai Li
NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
Journal of Neuroinflammation
Paclitaxel
NFATc2
CXCL14
Histone acetylation
Neuropathic pain
title NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
title_full NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
title_fullStr NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
title_full_unstemmed NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
title_short NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
title_sort nfatc2 dependent epigenetic upregulation of cxcl14 is involved in the development of neuropathic pain induced by paclitaxel
topic Paclitaxel
NFATc2
CXCL14
Histone acetylation
Neuropathic pain
url http://link.springer.com/article/10.1186/s12974-020-01992-1
work_keys_str_mv AT mengliu nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT subozhang nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT yuxuanluo nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT yanlingyang nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT xiangzhongzhang nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT boli nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT yanmeng nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT yuanjiechen nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT ruixianguo nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT yuanchangxiong nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT wenjunxin nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel
AT daili nfatc2dependentepigeneticupregulationofcxcl14isinvolvedinthedevelopmentofneuropathicpaininducedbypaclitaxel